Danaher Corporation vs Jones Lang LaSalle Inc — how do they compare? Danaher Corporation trades at $200.3 (market cap $140.88B), while Jones Lang LaSalle Inc trades at $333.73 (market cap $14.94B). The key difference: Danaher Corporation is far larger — about 9.4× Jones Lang LaSalle Inc's market cap, and Danaher Corporation pays a 0.8% dividend while Jones Lang LaSalle Inc pays none. Which is the better fit depends on your goals.
| DHR | JLL | |
|---|---|---|
Market Cap | $140.88B | $14.94B |
Sector | Health | Real Estate |
52-Week High | $242.05 | $358.66 |
52-Week Low | $161.91 | $248.95 |
Enterprise Value | $153.66B | $18.48B |
Dividend Yield | 0.8% | — |
Signals from Pluang's Aura AI — not financial advice
Danaher (DHR) trades at $200.16, up 0.56% today, with a bullish technical signal from moving averages and strong analyst support. The company reported Q1 2026 EPS of $2.06, beating estimates of $1.94, marking the third consecutive quarterly beat. Revenue for 2025 was $24.57 billion with a net income margin of 14.89%, though margins have compressed from prior years. Recent news includes the acquisition of Masimo and a $172.5 million legal settlement finalized in April 2026.
The outlook remains positive with a consensus price target of $211.33, implying ~5.6% upside, supported by 69% buy ratings. Key risks include margin pressure, integration challenges from acquisitions, and macroeconomic sensitivity. The stock offers a dividend yield from its $0.40 quarterly payout, with solid cash flow generation offsetting debt levels.
JLL trades at $321.95, down 0.77% today, with a bullish technical outlook supported by moving averages and strong support near $319. The company shows robust fundamentals with revenue growth to $26.12B in 2025 and consistent earnings beats, while valuation ratios like P/E of 17.32 and P/S of 0.58 appear reasonable. Recent news highlights significant refinancing deals and positive AI workforce studies, reinforcing business momentum.
JLL offers a favorable risk-reward profile with a consensus price target of $405.50 implying 26% upside, backed by analyst optimism and improving cash flows. Key risks include economic sensitivity to real estate cycles and competitive pressures. The stock presents a growth opportunity driven by operational execution and market leadership, though investors should monitor debt levels and macroeconomic trends.
Trailing returns across standard periods
Latest headlines on both assets
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in three segments: life sciences, diagnostics, and environmental and applied solutions. In late 2019, Danaher separated from its dental business through an initial public offering process, and in early 2020, it acquired GE's Biopharma business, now called Cytiva, which added to its life sciences segment.
Read more on DHR →Jones Lang LaSalle provides a wide range of real estate-related services to owners, occupiers, and investors worldwide, including leasing, property and project management, and capital markets advisory. JLL's investment management arm, LaSalle Investment Management, manages over $70 billion for clients across diverse public and private real estate strategies.
Read more on JLL →